OSUR
Orasure Technologies·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 4
Bearish Engulfing
Ample Liquidity
Significant Revenue Decline
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About OSUR
Orasure Technologies, Inc.
A global leader in point-of-care and home diagnostic testing and sample collection technologies
Healthcare Equipment and Supplies
--
01/30/1987
NASDAQ Stock Exchange
501
12-31
Common stock
220 East First Street
, Bethlehem
, Pennsylvania 18015
--
Orasure Technologies, Inc., was established in May 2000 and is incorporated under the laws of the State of Delaware. It merged two companies, STC Technologies and Epitope, and changed the situation of Epitope, moving from Oregon to Delaware. The Company's business primarily involves the development, manufacture, marketing and sale of oral liquid diagnostic products and sample collection devices using its proprietary oral fluid technology, as well as other diagnostic products including immunoassays and other in vitro diagnostic reagents. The company also manufactures and sells cryosurgical medical equipment for removal of benign skin lesions.
Earnings Call
Q1/2025
Estimate EPS-0.12
Actual EPS-0.18
Estimate Revenue29.57M
Actual Revenue29.93M
OraSure's Q1 2025: Unraveling Contradictions in PEPFAR Funding, Product Regulations, and Margin Expectations
May 08,2025 07:33
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.15
Actual EPS-0.19
Estimate Revenue30.36M
Actual Revenue31.24M
OraSure's Q2 2025: Unpacking Key Contradictions in Margins, Demand, and Revenue Outlook
Aug 05,2025 08:26
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
OSUR has released its 2025 Q3 earnings. EPS was reported at -0.13, versus the expected -0.16, beating expectations. The chart below visualizes how OSUR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
OSUR has released its 2025 Q3 earnings report, with revenue of 27.09M, reflecting a YoY change of -32.14%, and net profit of -13.71M, showing a YoY change of -204.24%. The Sankey diagram below clearly presents OSUR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
